- Home
- ATUS vs VRDN Comparison
ATUS vs VRDN Comparison
Compare ATUS & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATUS
- VRDN
- Stock Information
- Founded
- ATUS 2015
- VRDN 2006
- Country
- ATUS United States
- VRDN United States
- Employees
- ATUS N/A
- VRDN N/A
- Industry
- ATUS Cable & Other Pay Television Services
- VRDN Medical Specialities
- Sector
- ATUS Telecommunications
- VRDN Health Care
- Exchange
- ATUS Nasdaq
- VRDN Nasdaq
- Market Cap
- ATUS 1.1B
- VRDN 1.0B
- IPO Year
- ATUS 2017
- VRDN N/A
- Fundamental
- Price
- ATUS $2.23
- VRDN $13.97
- Analyst Decision
- ATUS Buy
- VRDN Strong Buy
- Analyst Count
- ATUS 7
- VRDN 12
- Target Price
- ATUS $2.75
- VRDN $38.50
- AVG Volume (30 Days)
- ATUS 4.4M
- VRDN 785.8K
- Earning Date
- ATUS 05-08-2025
- VRDN 05-06-2025
- Dividend Yield
- ATUS N/A
- VRDN N/A
- EPS Growth
- ATUS N/A
- VRDN N/A
- EPS
- ATUS N/A
- VRDN N/A
- Revenue
- ATUS $8,855,764,000.00
- VRDN $302,000.00
- Revenue This Year
- ATUS N/A
- VRDN N/A
- Revenue Next Year
- ATUS N/A
- VRDN $21,976.14
- P/E Ratio
- ATUS N/A
- VRDN N/A
- Revenue Growth
- ATUS N/A
- VRDN 4.86
- 52 Week Low
- ATUS $1.52
- VRDN $9.90
- 52 Week High
- ATUS $3.20
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- ATUS 40.47
- VRDN 56.41
- Support Level
- ATUS $2.29
- VRDN $13.37
- Resistance Level
- ATUS $2.52
- VRDN $14.18
- Average True Range (ATR)
- ATUS 0.14
- VRDN 0.68
- MACD
- ATUS -0.03
- VRDN 0.13
- Stochastic Oscillator
- ATUS 1.59
- VRDN 75.40
About ATUS Altice USA Inc.
Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).